Dopaminergic antiparkinsonism agents
https://themeditary.com/dosage-information/inbrija-dosage-645.html

Inbrija Dosage

Drug Detail:Inbrija (Levodopa inhalation capsules [ lee-voe-doe-pa ])

Generic Name: LEVODOPA 42mg

Dosage Form: respiratory (inhalation) capsule

Drug Class: Dopaminergic antiparkinsonism agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

INBRIJA capsules are for oral inhalation only and should be used only with the INBRIJA inhaler.

Important Administration Instructions

INBRIJA capsules are for oral inhalation only and should be used only with the INBRIJA inhaler. INBRIJA capsules must not be swallowed as the intended effect will not be obtained. INBRIJA capsules should be stored in their blister package and only removed immediately before use [see How Supplied/Storage and Handling (16.2)] .

Recommended Dosage

INBRIJA should be taken when symptoms of an OFF period start to return.

The recommended dosage of INBRIJA is oral inhalation of the contents of two 42 mg capsules (84 mg) as needed, up to 5 times a day. The maximum dose per OFF period is 84 mg, and the maximum daily dosage is 420 mg. INBRIJA has been shown to be effective only in combination with carbidopa/levodopa [see Indications and Usage (1)].

Share this Article
Latest News
Related Drugs